人才建設

您所在的位置: 首頁 - 人才建設 - 師資隊伍 - 準聘長聘教師 - 教授 - 血液病醫(yī)院

血液病醫(yī)院

  • 姓 名:

    王建祥

  • 單 位:

    中國醫(yī)學科學院血液病醫(yī)院(中國醫(yī)學科學院血液學研究所)

  • 教職崗位:

    教授

  • 聘任時間:

    2018-07-01

  • 一級學科:

    臨床醫(yī)學

  • 二級學科:

    內(nèi)科學(血液病)

  • 聯(lián)系方式:

    wangjx@ihcams.ac.cn

  • 導師風采鏈接:
    https://yzbss.pumc.edu.cn/basicinfo/tutorinfo/tutordetail/J2009140181

個人簡介

王建祥,1963年生,籍貫山東,血液學家,血液病醫(yī)院(血液學研究所)主任醫(yī)師,博士生導師。1980年考入山東醫(yī)學院醫(yī)學專業(yè),1985年獲得學士學位。1988-1991年在中國協(xié)和醫(yī)科大學醫(yī)學專業(yè)攻讀碩士學位,從事白血病臨床及基礎研究,期間在日本熊本大學醫(yī)學部研修一年。1994-1999年在美國NIH從事白血病發(fā)病機制研究。1991年升為主治醫(yī)師,1994年為副主任醫(yī)師,1999年為主任醫(yī)師。2019年任國家血液系統(tǒng)疾病臨床醫(yī)學研究中心主任。


主要研究內(nèi)容

主要從事白血病的臨床與基礎研究,探究白血病的發(fā)病機理、靶向治療和預后危險度分層治療,研發(fā)具有自主知識產(chǎn)權的抗白血病細胞的嵌合性抗原受體(CAR)及其修飾的T細胞(CAR-T)在白血病治療中的作用。


代表性成果

久久综合九色欧美综合狠狠_伊人热热久久原色播放WWW_成A人片亚洲日本久久_久久不见久久见免费影院www日本_97久久精品人人做人人爽,又色又爽又黄的视频在线观看,狼群影院视频在线观看高清版,亚洲AV无码精品网站性色,国产乱码久久久久久红粉影视,精品国产乱码久久久久久一区二区,国产精品免费视频网站,国产A级毛片久久久久久精品,一级特黄高清aaaa大片,亚洲中文字幕欧美一区,久久精品国产99久久狂热,黑人巨大精品欧美_黑人巨大精品欧美黑寡妇_黑人巨大精品欧美一区二区_黑人巨大精品欧美一区二区免费_黑人巨大跨种族video_黑人巨大无码中文字幕无码_黑人巨茎大战俄罗斯美女_黑人巨茎大战俄罗斯美女,中文字幕av不卡|亚洲欧美国产另类|天天干在线播放|日韩黄视频|欧美七区|可以免费看毛片的网站|黄色片在线|国产精品96久久久久久

1. Yu Zhang#, Saisai Li#, Ying Wang, Yang Lu, Yingxi Xu, Qing Rao, Huijun Wang Haiyan Xing, Zheng Tian, Kejing Tang, Lulu Lv, Min Wang*, Jianxiang Wang*, A novel and efficient CD22 CAR?T therapy induced a robust antitumor effect in relapsed/refractory leukemia patients when combined with CD19 CAR?T treatment as a sequential therapy, Exp Hematol Oncol, 2022, 11:15. (IF=8.593, 2021)

2. Yingxi Xu#, Junli Mou, Ying Wang, Wei Zhou, Qing Rao, Haiyan Xing, Zheng Tian, Kejing Tang, Min Wang*, Jianxiang Wang*, Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine related signaling pathway, Leukemia, 2022; 36(2): 403-415. (IF=12.897, 2021)

3. Nianci Chen#, Yingxi Xu#, Junli Mou, Qing Rao, Haiyan Xin, Zheng Tian, Kejing Tang, Min Wang*, Jianxiang Wang*, Targeting of IL-10R on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells, Blood Cancer J, 2021; 11(8): 144. (IF=9.812)

4. Runxia Gu#, Fang Liu#, Dehui Zou#, Yingxi Xu, Yang Lu, Bingcheng Liu, Wei Liu, Xiaojuan Chen, Kaiqi Liu, Ye Guo, Xiaoyuan Gong, Rui Lv, Xia Chen, Chunlin Zhou, Mengjun Zhong, Huijun Wang, Hui Wei, Yingchang Mi, Lugui Qiu, Lulu Lv, Min Wang, Ying Wang*, Xiaofan Zhu*, Jianxiang Wang*, Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia, J Hematol Oncol, 2020; 13(1): 122. (IF=17.338)

5. Hui Wei#, Ying Wang#, Robert Peter Gale, Dong Lin, Chunlin Zhou, Bingcheng Liu, Shaowei Qiu, Runxia Gu, Yan Li, Xingli Zhao, Shuning Wei, Benfa Gong, Kaiqi Liu, Xiaoyuan Gong, Yuntao Liu, Guangji Zhang, Zhen Song, Yang Wang, Wei Li, Yingchang Mi*, Jianxiang Wang*, Randomized trial of intermediate-dose cytarabine in induction and consolidation therapy in adults with acute myeloid leukaemia, Clin Cancer Res. 2020; 26(13): 3154-3161. (IF=12.531)

6. Li Zhang#, Li Meng#, Bingcheng Liu#, Yanli Zhang, Huanling Zhu, Jiuwei Cui, Aining Sun, Yu Hu, Jie Jin, Hao Jiang, Xi Zhang, Yan Li, Li Liu, Wanggang Zhang, Xiaoli Liu, Jian Gu, Jianhui Qiao, Guifang Ouyang, Xin Liu, Jianmin Luo, Ming Jiang, Xiaobao Xie, Jianyong Li, Chunting Zhao, Mei Zhang, Tonghua Yang, Jianxiang Wang*, Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study, Clin Cancer Res. 2021; 27(1): 70-77. (IF= 13.801)

7. Shuang Liu#, Yanyan Xing#, Wenting Lu, Shouyun Li, Zheng Tian, Haiyan Xing, Kejing Tang, Yingxi Xu, Qing Rao, Min Wang* and Jianxiang Wang*RUNX1 inhibits proliferation and induces apoptosis of t (8;21) leukemia cells via KLF4 mediated transactivation of P57, Haematologica, 2019; 104 (8):1597-1607. (IF=7.116)

8. Huan Li#, Na Zhao, Yihui Li, Haiyan Xing, Shuying Chen, Yingxi Xu, Kejing Tang, Zheng Tian, Min Wang, Qing Rao*, Jianxiang Wang*, c-MPL is a candidate surface marker and confers self-renewal, quiescence, chemotherapy resistance, and leukemia initiation potential in leukemia stem cells, Stem Cells, 2018; 36:1685–1696. (IF= 5.614)

9. Ying Wang#, Yingxi Xu#, Saisai Li, Jia Liu, Yanyan Xing, Haiyan Xing, Zheng Tian, Kejing Tang, Qing Rao, Min Wang*, Jianxiang Wang*, Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells, J Hematol Oncol. 2018; 11(1): 60. (IF= 8.731)

10. Yirui Chen#, Shouyun Li#, Chunlin Zhou, Chengwen Li, Kun Ru, Qing Rao, Haiyan Xing, Zheng Tian, Kejing Tang, Yingchang Mi, Baohong Wang, Min Wang*, Jianxiang Wang*, TBLR1 fuses to retinoid acid receptor alpha in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia, Blood, 2014, 124(6):936-945. (IF= 10.452)


主站蜘蛛池模板: 常山县| 扎鲁特旗| 西乡县| 凤翔县| 彰化县| 塔河县| 田林县| 威信县| 衡山县| 荥阳市| 纳雍县| 江西省| 巩留县| 威信县| 安化县| 理塘县| 黎城县| 瑞丽市| 上犹县| 庆阳市| 明光市| 华宁县| 扶风县| 水城县| 和林格尔县| 车险| 曲麻莱县| 增城市| 东乌| 阜南县| 阜康市| 拉萨市| 定西市| 秦皇岛市| 卢湾区| 江北区| 隆德县| 西丰县| 思南县| 肥东县| 呼图壁县|